Is OMER Worth Buying in 2026?

Omeros Corporation

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-08-16

Here’s whether Omeros Corporation (OMER) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+5.45% over 10 days); strong 1-year return of +317.2%; 3-month momentum positive (+40.3%); rising volume confirms the move (1.53x 30d avg). Concerns: RSI 91 — overbought, elevated pullback risk. Currently 5.2% off its 52-week high. Score: +6/7.

Ready to act on this? 📈 Trade on Webull

OMER is in a confirmed uptrend, trading above both its 50-day ($10.90) and 200-day ($11.28) moving averages. With an RSI of 91.3, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +317.2% compares to +20.4% for SPY (beat the market by 296.9%).

$10,000 invested 1 year ago → $41,723 today
vs. S&P 500 (SPY) — same period beat market by 296.9%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($11.28)
Above 50-day MA ($10.90)
!RSI(14) neutral zone (30–70) — currently 91.3
Positive return (+317.2%)
Within 10% of period high (−5.2%)
Period Range $17.19
$3.94 $18.14
RSI (14) 91.3
0 · OversoldOverbought · 100

Key Metrics

Price$17.19
Period Return+317.2%
Period High$18.14
Period Low$3.94
Drawdown−5.2%
MA-50$10.90
MA-200$11.28
RSI (14)91.3
Avg Volume (30d)2.0M
vs. SPYbeat by 296.9%
Return Rank#39 of 1252

Trade OMER

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers